Bryan Hinck

Roux-en-Y Gastric Bypass is Associated with Early Increased Risk Factors for Development of Calcium Oxalate Nephrolithiasis

BACKGROUND Patients treated for obesity with jejunoileal bypass (JIB) experienced a marked increased risk of hyperoxaluria, nephrolithiasis, and oxalate nephropathy developing. Jejunoileal bypass has been abandoned and replaced with other options, including Roux-en-Y gastric bypass (RYGB). Changes in urinary lithogenic risk factors after RYGB are currently unknown. Our purpose was to determine whether RYGB is associated with elevated risk of developing calcium oxalate stone formation through increased urinary oxalate excretion and relative supersaturation of calcium oxalate. STUDY DESIGN A prospective longitudinal cohort study of 24 morbidly obese adults (9 men and 15 women) recruited from a university-based bariatric surgery clinic scheduled to undergo RYGB between December 2005 and April 2007. Patients provided 24-hour urine collections for analysis 7 days before and 90 days after operation. Primary outcomes were changes in 24-hour urinary oxalate excretion and relative supersaturation of calcium oxalate from baseline to 3 months post-RYGB. RESULTS Compared with their baseline, patients undergoing RYGB had increased urinary oxalate excretion (31 +/- 10 mg/d versus 41 +/- 18 mg/d; p = 0.026) and relative supersaturation of calcium oxalate (1.73 +/- 0.81 versus 3.47 +/- 2.59; p = 0.030) 3 months post-RYGB in six patients (25%). De novo hyperoxaluria developed. There were no preoperative patient characteristics predictive of development of de novo hyperoxaluria or the magnitude of change of daily oxalate excretion. CONCLUSIONS This prospective study indicates that RYGB is associated with an earlier increase in urinary oxalate excretion and relative supersaturation of calcium oxalate than previously reported. Additional studies are needed to determine longterm post-RYGB changes in urinary oxalate excretion and identify patients that might be at risk for hyperoxaluria developing.

Flexible Ureteroscopy With a Ureteral Access Sheath: When to Stent?

OBJECTIVE To compare intra- and postoperative data of patients who underwent ureterorenoscopy (URS) with an access sheath, with and without postoperative stenting. METHODS We retrospectively identified patients who underwent flexible URS with a ureteral access sheath between January 2102 and January 2013. Two surgeons performed all cases; one who routinely stents after flexible ureteroscopy and a second who selectively stents. Fifty-one patients who were stented and 51 patients not stented after URS were enrolled in this study. Patients were matched by operative time as a surrogate measure of complexity of the procedure. Intra- and postoperative data were compared. We also analyzed if preoperative stenting or sheath diameter had any effect on postoperative pain score for each group. RESULTS Patients in the stented group were older (P <.001), had larger ureteral access sheaths (P <.001), and greater stone burden (P <.001). Despite this, the stented group had lower pain scores (4.5 ± 3.2 vs 8.9 ± 3.2; P = .025) and were less likely to seek medical assistance for pain than the unstented patients (26.3% vs 3.9%; P = .007). Patients who were prestented before ureteroscopy had lower pain scores than those who were not prestented in the group that did not receive a postoperative stent (4.2 ± 3.4 vs 6.6 ± 2.8; P = .047). CONCLUSION Postoperative stenting after flexible URS with a ureteral access sheath seems to decrease postoperative pain. Patients might be selected for no ureteral stent if they were prestented before the procedure, and the URS was uneventful.

Preoperative Prediction and Postoperative Surgeon Assessment of Volume Preservation Associated with Partial Nephrectomy: Comparison with Measured Volume Preservation

OBJECTIVE To evaluate whether surgeons can predict the percent parenchymal mass that will be preserved by partial nephrectomy (PN) based on preoperative imaging, which could have potential utility for preoperative surgical planning and patient counseling. The proportion of preserved viable parenchyma following PN is the primary determinant of functional recovery. However, direct measurement of parenchymal volume preservation (VP) can be complex and time consuming. MATERIALS AND METHODS For patients managed with PN at our institution (2007-2014), we randomly selected 45 with a third in each of low, intermediate, or high R.E.N.A.L. complexity groups. All patients had recorded postoperative surgeon assessment of volume preservation (SAVP) and measured VP based on preoperative or postoperative computed tomography. Nine clinical providers predicted VP based solely on review of preoperative imaging while blinded to SAVP and measured VP. Clinical experience of the providers ranged from medical students to experienced urologic surgeons. RESULTS Median age was 66 years, median tumor size was 4.0 cm, and median R.E.N.A.L. was 8. Median measured VP was 81% (interquartile range of 74-89%). Preoperative prediction of VP correlated poorly with measured VP among the different surgeons (mean correlation coefficient, R = 0.34, range = 0.24-0.40). Surgeon experience provided minimal incremental improvement. Correlation between R.E.N.A.L. and measured VP was also marginal (R = 0.43). In contrast, correlation between postoperative SAVP and measured VP was much more robust (R = 0.75, P <.001). CONCLUSION Preoperative prediction of VP and R.E.N.A.L. score correlated poorly with measured VP for patients managed with PN. In contrast, postoperative SAVP provided a relatively reliable estimate of VP, and should be considered an acceptable substitute in most clinical circumstances.

Comparative analysis of lighted ureteral stents: Lumination and tissue effects

PURPOSE The objectives of the present study were to compare the luminescence of three types of ureteral illuminated stents and analyze their effects on urothelial histology. MATERIALS AND METHODS Three types of illuminating ureteral stents; the Cook single illuminating catheter, Cook double illuminating catheter and Stryker illumination system stent were laparoscopically placed in nine female white pigs (50 kg), under general anesthesia. After leaving the stents illuminated for 3 hours, during which time peritoneal insufflation was maintained at 18 mm Hg, the ureter was transected and the intraluminal temperature of the ureter was measured with a digital thermometer. The ureteral tissue was then harvested for histologic evaluation, and the animal was euthanized. RESULTS Statistical analysis confirmed that Stryker and Cook double illuminated stents were equally efficient in illuminating the ureter (P 0.46) whereas, the Cook single stent was significantly superior (P = 0.000004). There was no significant difference in mean intraluminal temperatures between the Cook single (95.2 degrees F), Cook double (92.3 degrees F), and Stryker (95.1 degrees F) stents. When compared with the intraluminal temperature of control unstented ureters, no significant increase was noted with the Cook single (P = 0.85), Cook double (P = 0.57), or Stryker (P = 0.82). Histologic analysis did not show any evidence of thermal injury to the urothelium or any remarkable alteration in the ureteral mucosa. CONCLUSION The Cook single illuminated stent presented the highest luminescence. All three devices did not cause any remarkable injury to the urothelium after 3 hours of exposure.

Clinical Predictors of 30-Day Emergency Department Revisits for Patients with Ureteral Stones

PURPOSE Patients with ureteral stones frequently present to the emergency department for an initial evaluation with pain and/or nausea. However, a subset of these patients subsequently return to the emergency department for additional visits. We sought to identify clinical predictors of emergency department revisits. MATERIALS AND METHODS We reviewed emergency department visits at our institution with an ICD-9 diagnosis of urolithiasis and an associated computerized tomography scan between 2010 and 2013. Computerized tomography studies were independently reviewed to confirm stone size and location, and degree of hydronephrosis. The primary outcome was a second emergency department visit within 30 days of the initial visit for reasons related to the stone. Patient characteristics and stone parameters at presentation were recorded. Univariable and multivariable analyses were done to identify factors associated with emergency department revisits. RESULTS We reviewed the records of 1,510 patients 18 years old or older who presented to the emergency department with a diagnosis of ureteral stones confirmed by computerized tomography. Of the patients 164 (11%) revisited the emergency department within 30 days. On multivariable analysis the presence of a proximal ureteral stone, age less than 30 years and the need for intravenous narcotics in the emergency department remained independently associated with an emergency department revisit. CONCLUSIONS Younger patients, those with proximal stones and those requiring intravenous narcotics for pain control are more likely to return to the emergency department. Consideration should be given for early followup or intervention for these patients to prevent costly emergency department returns.

Can a Simplified 12-Hour Nighttime Urine Collection Predict Urinary Stone Risk?

OBJECTIVE To determine if there is correlation between nighttime 12-hour and traditional 24-hour urine collection in regard to chemistry values and the supersaturations of calcium oxalate, calcium phosphate, and uric acid for the metabolic evaluation of nephrolithiasis. MATERIALS AND METHODS Ninety-five patients were prospectively enrolled from 2013 to 2015. Patients >18 years of age who presented to a tertiary stone clinic and who would normally be counseled for 24-hour urine collection were eligible for the study. Participants completed 24-hour urine collections twice, with each divided into 2 separate 12-hour collections. Day-time collection began after the first morning void and continued for 12 hours. The night collection proceeded for the next 12 hours through the first morning void. RESULTS Forty-nine 24-hour samples from 35 patients met inclusion criteria and were included in the analysis. Overall, there was strong correlation between the night 12-hour and the 24-hour urine collections with R2 ranging from 0.76 for pH to 0.96 for Citrate. In our analysis of variability, the nighttime 12-hour collection differed from the 24-hour collection by 30% in 1-9 patients (2.0%-18.4%) based on individual chemistry value. Diagnosis of underlying metabolic abnormalities was concordant in 92% of patients. CONCLUSION A 12-hour nighttime collection has strong correlation with 24-hour urine collection. As such, simplifying the metabolic evaluation to a 12-hour overnight collection may be feasible-improving compliance and decreasing patient burden.

Inflammatory cytokines in the papillary tips and urine of nephrolithiasis patients

INTRODUCTION Intrarenal inflammation has been implicated in the pathogenesis of nephrolithiasis, with prior work showing increased urine levels of IL-6, IL-8, and CCL-2 in stone patients. However, no studies have assessed for inflammation in the renal papillae. We sought to characterize novel papillary tip and urinary biomarkers in stone patients. MATERIALS AND METHODS Ninety-two patients with nephrolithiasis undergoing percutaneous nephrolithotomy were enrolled. Papillary tip biopsies, kidney urine, and bladder urine were collected, as well as voided urine from eight healthy volunteers. Quantitative polymerase chain reaction was performed to measure inflammatory gene expression. RESULTS Initial 84-gene polymerase chain reaction array revealed significant elevation of several cytokines in stone patients vs controls (fold change 2.3-694). Twenty-four genes were selected for final analysis. In 41 pairs of urine samples, levels of CCL5, CD40, FasL, RIPK2, SELE, TLR3, and IL-15 were significantly elevated in kidney vs bladder urine (p0.0001-0.04). In 23 triplets of samples, expression of these cytokines plus CCL2, CCL7, CCR2, CSF1, CXCL9, and CXCL10, was significantly greater in papillary tips vs urine samples (p0.001-0.05). Cytokine elevation was independent of maximum postoperative heart rate, respiratory rate, temperature, leukocyte count, urinary tract infection in the past year, presence or absence of antibiotics at the time of surgery, and stone composition (all p > 0.05). CONCLUSION Expression of CCL-2, CCL-5, CCL-7, CCR-2, CD40, CSF1, CXCL-9, CXCL-10, Fas-L, RIPK2, SELE, and TLR-3 is markedly elevated in the papillary tips, kidney urine, and bladder urine of nephrolithiasis patients. Cytokine elevation was independent of signs of systemic inflammation. These findings further support the role of inflammation in nephrolithiasis and imply that the inflammatory process likely begins at the renal papillae. These may represent novel biomarkers of stone disease, which may be useful in basic nephrolithiasis research, disease diagnosis, and prognosis.

Hybrid guidewires: Analysis and comparison of the mechanical properties and safety profiles

INTRODUCTION Hybrid guidewires are commonly used in urology due to the advantage of an atraumatic hydrophilic tip, which facilitates negotiating tight areas, coupled with an unkinkable nitinol core shaft that is easy to work over due to the Teflon coating. Our aim was to compare the physical and mechanical properties of five commercially available hybrid guidewires to assess their characteristics and functionality. METHODS In vitro testing was performed on the following straight-tipped 0.035 inch guidewires: Sensor™ (Boston Scientific), Solo™ Plus (Bard), UltraTrack (Olympus), Rio Tracer™ (Rocamed), and Motion™ (Cook). We evaluated characteristics impacting function (tip flexibility, shaft stiffness, lubricity) and safety (perforation force). Measurements included tip flexibility, lubricity, shaft buckling, and force required to perforate a sheet of aluminum foil. RESULTS The Motion had the highest tip-bending force (p<0.00001). The Rio Tracer had the stiffest shaft (p<0.00001), followed by the Solo Plus and the Motion, which were significantly stiffer than the Sensor and UltraTrack (p<0.00001). The Solo Plus and UltraTrack had the greatest perforation force (p=0.00023), and the Rio Tracer had the lowest perforation force (p=0.016) when compared to the Sensor. There was no significant difference in frictional force between the five guidewires (p=0.1516). CONCLUSIONS The Solo Plus and UltraTrack required the greatest force to perforate, which conveys a higher safety margin. The RioTracer is the stiffest guidewire, which may be beneficial for instrument insertion with the tradeoff of having a lower perforation force. The clinical significance of higher tip-bending forces (unfavourable) and higher shaft-bending forces (favourable) deserve further investigation.

Tipless Nitinol Stone Baskets: Comparison of Penetration Force, Radial Dilation Force, Opening Dynamics, and Deflection

OBJECTIVE To evaluate 5 commercially available tipless nitinol baskets (2.2F) in 4 performance factors: penetration force, radial dilation force, opening dynamics, and deflection limitation. MATERIALS AND METHODS The 2.2F Coloplast Dormia No-Tip, 1.5F Sacred Heart Medical Halo, 2.2F Cook NCircle Nitinol Tipless Stone Extractor, 1.9F Bard SkyLite Tipless Nitinol Basket, and 1.9F Boston Scientific Zero Tip Nitinol Stone Retrieval Basket were tested for penetration force (safety metric), radial dilation force (functional metric for ureteral calculi), and opening or closing dynamics. Limitation of deflection (functional metric) was tested by measuring the difference in maximal upward and downward angle of deflection of a ureteroscope with and without a basket in place. RESULTS The Sacred Heart Medical Halo 1.5F basket had the highest mean force required to perforate the foil at 0.676N ± 0.117 (P < .0001). The Sacred Heart Medical Halo 1.5F basket also had the highest mean radial dilation force at 3.04 g ± 0.15 (P < .0001). The Cook NCircle Nitinol Tipless Stone Extractor 2.2F had the most linear pattern of opening, whereas the Coloplast Dormia No-Tip 2.2F and the Sacred Heart Medical Halo 1.5F exhibited exponential opening dynamics. The Cook NCircle Nitinol Tipless Stone Extractor 2.2F limited scope deflection the most with a decrease in 4° downward and 10° upward. The Sacred Heart Medical Halo 1.5F had the least influence on deflection with a decrease in 3° downward and 5° upward. CONCLUSION The penetration force, radial dilation force, opening dynamics, and resistance to deflection varied between 5 commonly available tipless nitinol stone baskets. A small diameter 1.5F basket is capable of providing optimal performance while sacrificing linear opening.

MP12-07 URINE KIDNEY INJURY MARKERS DO NOT INCREASE FOLLOWING GASTRIC BYPASS: A MULTI-CENTER CROSS-SECTIONAL STUDY.

INTRODUCTION To determine if markers of kidney injury correlate with urinary oxalate excretion. If so, such biomarkers might be early predictors of oxalate nephropathy. Gastric bypass surgery for obesity is known to be associated with postoperative hyperoxaluria, which can lead to urolithiasis and kidney damage. MATERIALS AND METHODS Patients were recruited from four large academic centers > 6 months following completion of gastric bypass surgery. Patients provided a spot urine sample for analysis of three markers of kidney injury: 8-iso-Prostaglandin F2 α, N-acetyl- β -D-Glucosaminidase, and Neutrophil gelatinase-associated lipocalin. Patients also provided 24 hour urine samples for stone risk analysis. RESULTS A total of 46 study patients provided samples, the average age was 48.4 +/- 11.3. There were 40 women and 6 men. There was no difference in the level of any of the three inflammatory markers between the study group and the reference range generated from healthy non-hyperoxaluric subjects. Neither oxalate excretion nor supersaturation of calcium oxalate correlated with any of the injury markers. There was no difference noted between those with hyperoxaluria (n = 17) and those with normoxaluria (n = 29) with respect to any of the injury markers. CONCLUSIONS Though hyperoxaluria was common after bypass surgery, markers of kidney injury were not elevated after surgery. No correlation was found between urine oxalate excretion and any of the injury markers.